News
-
Corum in the black
Tuesday | Sep 4 2018LISTED pharmacy software specialist Corum Group Limited has recorded a $251,000 net profit after tax for the year to 30 Jun, a significant turnaround on last year's $5.9 million full year loss which included a significant non-cash goodwill impairment.
-
Nabiximols S4 comments sought
Tuesday | Sep 4 2018THE Therapeutic Goods Administration is inviting comments on a proposal to reschedule Sativex (nabiximols) from its current S8 classification to Schedule 4.
-
Paramedic AHPRA
Tuesday | Sep 4 2018THE Australian Health Practitioner Regulation Agency has opened applications for paramedic registration, in the lead-up to the start of regulation of paramedics under the National Registration and Accreditation scheme later this year.
-
Asthma blindness
Tuesday | Sep 4 2018A NEW national poll shows that asthma impacts the lives of 63% of Australians, yet 31% are unaware that the disease is life-threatening and long term, Asthma Australia said at the launch of National Asthma Week last Sun.
-
S19A amiloride tick
Tuesday | Sep 4 2018HL PHARMA has been awarded Section 19A(1) approval by the Therapeutic Goods Administration to supply amiloride 5mg tablets.
-
Dispensary Corner
Tuesday | Sep 4 2018
04 Sep 18AUTHORITIES in Kuwait have reportedly ordered the closure of a fish shop after it was found to be sticking fake eyes on its produce to make it look fresher.
-
Guild Update 04 Sep 18
Tuesday | Sep 4 2018INFLUENZA statistics reflect well on community pharmacy.
-
FIP congress to Australia
Monday | Sep 3 2018THE International Pharmaceutical Federation (FIP) has confirmed it will hold the World Congress of Pharmacy and Pharmaceutical Sciences in Brisbane in three years' time (PD breaking news Sat).
-
Pharmacist thief banned
Monday | Sep 3 2018A WEST Australian pharmacist has been disqualified from applying for registration for six months after being found guilty of stealing money and goods from his employer.
-
Paracetamol to S3?
Monday | Sep 3 2018THE Therapeutic Goods Administration (TGA) has asked the Advisory Committee on Medicines Scheduling (ACMS) to consider whether one form of paracetamol - modified release (MR) paracetamol - should become a 'Pharmacist Only' medicine.
